₹ 0.5 Cr
Volume Transacted
(Nov 22, 2024)
3.4 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
Ipca Laboratories Ltd
NSE: IPCALAB
ISIN
INE571A01038
Last updated on: Nov 23, 2024
Open Demat Account
Enter your mobile no. to continue
+91
*By signing up you agree to our terms & conditions
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
Ipca Laboratories Ltd
NSE: IPCALAB
Share Price
₹ 1590.55
17.35 (1.10%)
Last updated on: Nov 22, 2024
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 1590.55 | 1578.65 | 1597.8 | 1568.25 |
21 Nov 2024 | 1573.2 | 1571.75 | 1586.8 | 1555.95 |
19 Nov 2024 | 1573.1 | 1568 | 1605.75 | 1560 |
18 Nov 2024 | 1566.85 | 1566.85 | 1594.25 | 1508.15 |
14 Nov 2024 | 1536.95 | 1475.35 | 1554 | 1475.35 |
13 Nov 2024 | 1508.15 | 1563.65 | 1568.35 | 1494.05 |
12 Nov 2024 | 1557.15 | 1555 | 1609 | 1546.3 |
11 Nov 2024 | 1531.5 | 1580 | 1587.8 | 1516.1 |
08 Nov 2024 | 1556.65 | 1563.1 | 1575 | 1549.2 |
07 Nov 2024 | 1557.55 | 1583.25 | 1615.3 | 1552.6 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 1590.55 |
21 Nov 2024 | 1573.2 |
19 Nov 2024 | 1573.1 |
18 Nov 2024 | 1566.85 |
14 Nov 2024 | 1536.95 |
13 Nov 2024 | 1508.15 |
12 Nov 2024 | 1557.15 |
11 Nov 2024 | 1531.5 |
08 Nov 2024 | 1556.65 |
07 Nov 2024 | 1557.55 |
Company Name | ISIN Code |
---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Company Name | ISIN Code |
---|---|
Cipla Ltd | INE059A01026 |
Torrent Pharmaceuticals Ltd | INE685A01028 |
Sun Pharmaceuticals Industries Ltd | INE044A01036 |
Divis Laboratories Ltd | INE361B01024 |
Mankind Pharma Ltd | INE634S01028 |
Last updated time: 23 Nov 12:45 PM
Market Value
₹ 0
Asset Value
₹ 0
* All values are in Rupees
Historical Revenue of Ipca Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
Historical Net Profit of Ipca Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Ipca Laboratories Ltd up for third straight session
Ipca Laboratories Ltd gained for a third straight session today. The stock is quoting at R...
19 Nov 202413:05
Board of Ipca Laboratories recommends Interim Dividend
Ipca Laboratories announced that the Board of Directors of the Company at its meeting held...
14 Nov 202415:29
Ipca Labs rises as Q2 PAT climbs 58% YoY to Rs 229 cr
Profit before tax surged 53.01% to Rs 344.83 crore in the September 2024 quarter from Rs 2...
14 Nov 202414:54
Ipca Laboratories schedules board meeting
Ipca Laboratories will hold a meeting of the Board of Directors of the Company on 14 Novem...
25 Oct 202411:15
Board of Ipca Laboratories approves consolidation of USA generic formulations biz
The Board of Ipca Laboratories at its meeting held on 30 September 2024 has approved enter...
30 Sep 202418:44
Ipca Laboratories Ltd soars 1.97%, up for third straight session
Ipca Laboratories Ltd rose for a third straight session today. The stock is quoting at Rs ...
25 Sep 202413:05
Unlimited trading at just
Rs. 199*